VanEck ETF Trust - VanEck Morningstar Wide Moat Value ETF
MVAL
Chicago Board Options Exchange- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- VanEck ETF Trust - VanEck Morningstar Wide Moat Value ETF is an exchange-traded fund launched on March 26, 2024, that seeks to track, before fees and expenses, the price and yield performance of the Morningstar US Broad Value Wide Moat Focus Index. The fund provides equity-market exposure primarily to U.S. value-oriented companies that Morningstar’s equity research team identifies as having sustainable competitive advantages, or wide economic moats, and that trade at attractive discounts to Morningstar fair-value estimates. MVAL employs an index-replication investment approach and invests principally in common stocks included in the underlying index; its portfolio spans consumer staples, health care, industrials, consumer discretionary, financials, information technology, materials and communication services companies, with predominant U.S. exposure and limited exposure to issuers in the Netherlands and Brazil. As of September 2026, principal portfolio holdings include Bristol-Myers Squibb Co., Danaher Corp., Zimmer Biomet Holdings Inc., Brown-Forman Corp., Kenvue Inc., The Clorox Co., Constellation Brands Inc., GE HealthCare Technologies Inc., Microsoft Corp., The Charles Schwab Corp., Thermo Fisher Scientific Inc., MarketAxess Holdings Inc., U.S. Bancorp, Otis Worldwide Corp., Masco Corp., Nike Inc., Broadridge Financial Solutions Inc., Tractor Supply Co. and United Parcel Service Inc. The fund distributes income annually and is advised by Van Eck Associates Corp.; VanEck ETF Trust is affiliated with VanEck, a New York-headquartered investment-management organization founded in 1955. Recent developments include MVAL’s continued operation as VanEck’s value-focused addition to its Morningstar Moat ETF suite, ongoing quarterly index reconstitutions reflecting Morningstar’s research-driven assessment of valuation and economic-moat characteristics, and a contractual net expense ratio of 0.50%, including an expense waiver scheduled through February 1, 2027.